ATLANTA, GA – November 3, 2015 – Zywie is advancing telemedicine with its remote cardiac monitoring solution, ZywiePro. It is revolutionizing the cardiovascular industry by lowering associated risks through FDA cleared, sensitive and accurate arrhythmia detection technology. Zywie helps physicians efficiently and accurately diagnose and treat their patients’ many heart-related problems. ZywiePro, the next-generation cardiac remote monitoring…

ATLANTA (February 22, 2016) – Zywie, a medtech company focused on the early detection and precise remote monitoring of patients with cardiovascular disease, has been named one of the Top 40 Innovative Technology Companies in Georgia by the Technology Association of Georgia (TAG), the state’s leading association dedicated to the promotion and economic advancement of…

ATLANTA (December 8, 2016) – Zywie, a medtech company that uses technology to improve the early detection and precise remote monitoring of patients with cardiovascular disease (CVD), was honored as the winner of the Intel Innovation Award competition and was also named Startup Company of the Year by the Metro Atlanta Chamber. The Intel Innovation Award…

ATLANTA, GA–(Marketwired – Jan 26, 2017) – Latha Ganeshan, the CEO and founder of Zywie, has been named a 2017 Innovation Award Winner by Georgia Bio, the state’s life science industry association. The Georgia Innovation Award honors the department, institution, company or individuals who are forging new ground by thinking outside traditional paradigms to create…

AT&T and Zywie are looking to offer highly secure, accessible monitoring for those with the disease as the Internet of Things is changing the healthcare industry by securely delivering valuable data in near real time, the companies said. The ZywiePro system uses mobile and cloud technology to detect cardiovascular arrhythmias in patients. It sends doctors…

Zywie’s Next-Generation Remote Cardiac Monitoring Solution Revolutionizing Decades-Old Solution ATLANTA (September 14, 2017) – Zywie, a health IT company using technology to improve the early detection and precise remote monitoring of patients with cardiovascular disease (CVD), has been selected to participate in the Startup Showcase at the 2017 Venture Atlanta. The 10th annual event will be…

Johns Creek – Since early this year, the world has been extraordinarily challenged by a novel coronavirus, COVID-19. Like all of us, Zywie remains committed to doing what is right for our patients, our customers, and our employees. Zywie has taken extra steps to ensure no disruption to our product supplies, staffing, and support personnel. …

Atrial fibrillation (AF) is one of the most common cardiovascular problems, and its asymptomatic tendency makes AF detection challenging. Machine and deep learning methods are commonly used in AF detection. The purpose of this study was to evaluate the information provided by convolutional neural network (CNN) and random forest (RF) machine learning models for AF…

August 2020 — Johns Creek, GA Zywie Healthcare announced today that the ZywieNano Patch™ Remote Patient Monitoring System is available. Jack Whittaker, Chief Operating Officer, said “Form factor is becoming an increasingly important aspect of RPM (remote patient monitoring) and launching the ZywieNano Patch™ allows all Zywie patients the ability to wear one of the…

HFSA abstract study demonstrating the efficacy of the ZywieAI® algorithm in detecting episodes of sustained and/or non-sustained WCTs like ventricular tachycardia, ventricular flutter, and ventricular fibrillation. Read full abstract here.

This study suggests that long-term outpatient monitoring can provide better diagnosis, especially for patients at a higher risk of developing critical arrhythmias. Read full abstract here.

Over $6.5 billion in funding awarded to date; leading tech investment conference continues to select large and diverse lineup of innovators from the Southeast’s hottest tech markets ATLANTA, Sept. 22, 2021 (GLOBE NEWSWIRE) — Zywie® announced today that it has been chosen out of a record-breaking 400-plus applicants as one of the top technology companies in the…

This study aims to identify if cardiac monitoring with a 30-day MCT patch provides better patient outcome than with the 24-hr Holter. To do so, we compared the arrhythmia and ectopy diagnostic yield of both modalities. Read full article here.

Ventricular Arrhythmias (VA), including Ventricular Tachycardia, Ventricular Fibrillation, and Ventricular Flutter, are life-threatening arrhythmias that can lead to sudden cardiac death. A Mobile Cardiac Telemetry (MCT) monitor facilitates continuous cardiac monitoring for timely diagnosis of all arrhythmias including VA. This study aims to identify VA in near-real-time using a single-lead ECG as short as 2…

Lovell® Government Services is pleased to announce a partnership with Zywie Healthcare, an innovator in wearable cardiac monitoring solutions. Lovell will represent Zywie as their Service-Disabled Veteran-Owned Small Business (SDVOSB) Vendor in the federal space. “As a growing company committed to improving patient care through continual advancements in heart monitoring technology, we look forward to the…

“Entrepreneur Of The Year” celebrates ambitious entrepreneurs who are shaping the future Atlanta, GA, April 25 – Ernst & Young LLP (EY US) today announced that CEO Latha Ganeshan of Zywie, Inc. was named an Entrepreneur Of The Year® 2024 Southeast Award finalist The Southeast program celebrates entrepreneurs from Alabama, Georgia, North Carolina, South Carolina…